BIOBIJOU Co.,Ltd. (KOSDAQ:489460)
South Korea · Delayed Price · Currency is KRW 11,700
-520 (-4.26%)
At close: Oct 21, 2026
BIOBIJOU Revenue
BIOBIJOU had revenue of 9.88B KRW in the quarter ending June 30, 2026, with 58.34% growth. This brings the company's total for the last twelve months to 28.56B, down -16.01% year-over-year. In the year 2025, BIOBIJOU had annual revenue of 28.49B, down -3.86%. That makes BIOBIJOU the 33,399th largest company in the world by revenue and 2,129th in South Korea.
Revenue (ttm)
28.56B
Revenue Growth
-16.01%
P/S Ratio
6.04
Revenue / Employee
679.95M
Employees
42
Market Cap
172.61B
Revenue by Geography
- China 19.03B 66.8%
- Korea 7.39B 25.9%
- Other 2.08B 7.3%
Fiscal year ended Dec 31, 2025 See the full BIOBIJOU breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 28.49B | -1.14B | -3.86% |
| Dec 31, 2024 | 29.63B | 12.50B | 72.99% |
| Dec 31, 2023 | 17.13B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.